The nuclear factor kappa B (NFκB) family of transcription factors is a key regulator of immune development, immune responses, inflammation, and cancer. The NFκB signaling system (defined by the interactions between NFκB dimers, IκB regulators, and IKK complexes) is responsive to a number of stimuli, and upon ligand-receptor engagement, distinct cellular outcomes, appropriate to the specific signal received, are set into motion. After almost three decades of study, many signaling mechanisms are well understood, rendering them amenable to mathematical modeling, which can reveal deeper insights about the regulatory design principles. While other reviews have focused on upstream, receptor proximal signaling ( 2014, 2:131), in this review we aim to summarize the current understanding of the NFκB signaling system itself, the molecular mechanisms, and systems properties that are key to its diverse biological functions, and we discuss remaining questions in the field.
INTRODUCTION
N uclear factor kappa B (NFκB) is a family of dimeric transcription factors central to coordinating inflammatory responses; innate and adaptive immunity; and cellular differentiation, proliferation, and survival in almost all multicellular organisms. [1] [2] [3] [4] The NFκB system is tightly regulated, and misregulation of NFκB has been implicated in a wide range of diseases ranging from cancers to inflammatory and immune disorders. As a result, the NFκB regulatory network and its dynamics offer a multitude of promising therapeutic targets that remain to be fully explored and translated into clinical use. [5] [6] [7] However, there continues to be an untapped potential for finer grained therapeutic targeting of the NFκB signaling system that requires a quantitative understanding of dynamical control and the integration of various physiological and pathological signals and stimuli. [8] [9] [10] In Mammalia, the NFκB network consists of five family member protein monomers (p65/RelA, RelB, cRel, p50, and p52) that form homodimers or heterodimers that bind DNA differentially [11] [12] [13] [14] and are regulated by two pathways: the canonical, NFκB essential modulator (NEMO)-dependent pathway and the noncanonical, NEMO-independent pathway. These pathways tightly control the levels and dynamics of the transcriptionally active NFκB dimer repertoire constitutively and in response to stimuli, and thus control broad gene expression programs 15, 16 via the recruitment of co-activators 17 or interplay with other transcription factors. 18, 19 The activation pathways control NFκB activity through multiple mechanisms: degradation of IκB inhibitor proteins, processing of NFκB precursor proteins, and expression of NFκB monomer proteins. 10, 20 Signals from tumor necrosis factor receptor (TNFR), toll-like receptor (TLR) superfamilies, interleukin receptor (IL-1R) and metabolic genotoxic, and shear stresses are integrated by the IκB/NFκB signaling network to produce signal-specific, context-specific, and celltype-specific transcriptional responses. [21] [22] [23] CANONICAL SIGNALING
Signaling via the NEMO-Associated IKK Complex
The canonical NFκB signaling pathway (a.k.a. NEMO-dependent pathway) is mediated by kinase complexes consisting of the scaffold/adaptor protein NEMO (a.k.a. IKKγ) and two IκB kinases (IKK1/2, a.k.a. IKKα and IKKβ) ( Figure 1(a) ). This IKK complex is activated by mechanisms that are NEMO dependent. The IKK kinases are activated by phosphorylation of serines in the activation T-loop, characteristic of the MAPK superfamily, and three mechanisms for IKK activation have emerged:
(1) NEMO multimerizes IKK subunits 27 to allow for activation via trans-autophosphorylation, (2) and/or brings them in proximity to upstream kinases such as TAK1, 28 which may also lead to mutual activation forming positive feedback and digital dose-response characteristics. 29, 30 These mechanisms are mediated by NEMO's ubiquitin-binding domain that allows for IKK's recruitment to nondegradative K63-linked ubiquitin chains, which are a hallmark of inflammatory signaling. Finally, (3) NEMO itself is a substrate of ubiquitination, particularly linear ubiquitin chains produced by the LUBAC enzyme, 31 which also facilitates the formation of transient signalsomes.
A wide variety of inflammatory cytokines (such as TNF and IL-1), a wide variety of pathogenassociated molecular patterns (PAMPs), or antigen/ immune stimulatory signals result in IKK phosphorylation-dependent activation of the NEMOcontaining complex, by one or a subset of these mechanisms, 24 resulting in complex dynamical control. 32 Once activated, the complex binds to and phosphorylates IκB proteins on specific serines in the N-terminal, leading to ubiquitination and subsequent proteasomal degradation. 25 The degradation of inhibitors releases NFκB dimers associated with them, freeing NFκB dimers and allowing them to bind κB site-containing DNA and thus rapidly accumulate in the nucleus. Following IκB release the NFκB subunits are subject to a variety of posttranslational modification that fine-tune gene-expression control. 33 Further, NEMO was shown to function as a scaffold between IKK and IκBα, thereby directing IKK activity to IκBα. 34 This mechanism ensures that the activation of NFκB dimers associated with IκBα, which is RelA:p50 in most cells and conditions, is directly linked to signals propagating through the NEMO hub. Hence, canonical signaling is often thought to be synonymous with RelA activation, but this is not always the case. In inflammatory dendritic cells, IκBα was also shown to be associated with FIGURE 1 | The canonical nuclear factor κ B (NFκB) activation pathway. (a) Schematic depiction of the canonical NFκB signaling pathway. Multiple inflammatory signals activate the complex containing NEMO and IKK1/2. IKK1/2 phosphorylates NFκB-bound IκBs, targeting them for ubiquitination and proteasomal degradation. 24, 25 Free IκBs also undergo constitutive degradation via a ubiquitin-independent proteasomal degradation pathway. As IκBs are degraded, free NFκB is then able to translocate to the nucleus where it binds to κB sites on DNA and activates gene expression. 21, 22 IκBα, β, and ε are themselves NFκB target genes, along with p100 that can form higher-molecular-weight complexes that inhibit NFκB. 25, 26 (b) Diagram of the regulatory logic of the canonical NFκB signaling network. Canonical signals activate NEMO/IKK, downregulating IκBs and reducing inhibition of NFκB. Free NFκB then translocates to the nucleus where it upregulates IκBs and p100 and in turn IκBδ.
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RelB:p50 dimers, thus rendering RelB a key transcriptional effector of the canonical NFκB pathway in that cell type. 35 While the activation mechanism of IKK is beginning to be elucidated with the aid of recent structural and biophysical characterizations 36, 37 and, for example, combined single-cell computational studies that have identified distinct pathways for robust digital responses and noisy sustained responses, 38 how IKK is inactivated remains unclear. One attractive proposal is that IKK is regulated in an autocatalytic cycle of at least three states in which activation occurs from a poised state and is followed by an inactive state. While the dynamic properties of such a kinase control cycle have been studied, 39 the biophysical evidence remains scant, but could involve trans-autophosphorylation of an inhibitory C-terminal domain in IKKβ 40 and/or conformational changes of the complex. 41 
IκBα Negative Feedback
Among the target genes regulated by κB sites are the IκBs that, upon transcriptional induction and resynthesis, are able to translocate to the nucleus, bind to and inhibit NFκB activity, trafficking it back to the cytosol. This constitutes the primary component of the self-regulating negative feedback loop 25 ( Figure 1(b) ). This feedback loop not only prevents run-away NFκB activity in response to transient inflammatory signals but also poises the system for reactivation when IKK activity is longer lasting. IκBα negative feedback has been studied in some detail with a combined experimental and mathematical modeling approach, and interesting properties have emerged: (1) Given the delay intrinsic to IκBα resynthesis, even very transient cytokine exposure (1 min TNF) results in almost a full hour of NFκB activity. 42 That 1 h of NFκB activity is invariant to the duration of the signal unless the incoming signal lasts longer than approximately 45 min. (2) Transcriptional induction of IκBα is necessary but not sufficient for mediating this effective negative feedback control of NFκB activity. 43 IκBβ, when controlled by an NFκB-inducible promoter, is unable to provide normal physiologically observed negative feedback 44 ; nuclear import, export, and protein degradation mechanisms specific to IκBα are critically important to recapitulating proper negative feedback and the NFκB dynamic responses characteristic of normal activity. [45] [46] [47] [48] [49] In addition, IκBα has been shown to be able to strip NFκB off DNA (or associate with chromatin 50 ), a function that IκBβ does not possess. 51 (3) Given effective IκBα negative feedback, stimulation conditions that produce longer lasting IKK activities allow for repeated cycles of reactivation, leading to oscillatory NFκB activity observed in biochemical bulk population assays 25 or single-cell assays. 38, [52] [53] [54] Intrinsic variability in the kinetic mechanisms that govern IκBα feedback is thought to render the oscillatory behavior more robust to variations in dynamic signals. 55, 56 However, the potential function of NFκB oscillations remains unclear, and no satisfying answer has been presented as to how such oscillations are interpreted by downstream gene regulatory networks.
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IκBδ Negative Feedback
Another transcriptional target gene that is induced by nuclear NFκB activity is the nfkb2 gene, which produces the p100 protein.
4 p100 was first known as the precursor for the p52 protein, a dimerization partner of RelB and potentially other Rel proteins. However, p100 that is not processed to p52 is able to form higher-molecular-weight complexes that are capable of binding to NFκB, acting as an IκB, termed IκBδ. 26 As such, NFκB control of nfkb2 forms another negative feedback loop that may terminate NFκB signaling. 58 However, transcriptional induction and protein synthesis are slow, in part due to the length and half-life of the mRNA and protein, and the subsequent required oligomerization step also takes several hours. 59 Thus, in contrast to IκBα that functions rapidly, IκBδ's role is primarily in attenuating persistent signals. 58 Indeed, while IκBα negative feedback is reversible as it is a sensitive substrate for continued canonical IKK activity, IκBδ is insensitive to canonical signals and thus attenuates the canonical pathway regardless of whether incoming signals persist. Further, because IκBδ has a longer half-life than other IκBs, it contributes to a signaling memory in which sequential stimulation events are dampened. 58 However, as a substrate for noncanonical signaling (see below), IκBδ is a signaling crosstalk node that integrates canonical and noncanonical signals that may result in noncanonical signals emanating from LTβR or BAFF to activate (or prolong the activation of ) NFκB RelA or cRel dimers.
26,60,61
Other Feedback Mechanisms
There are several other negative and positive feedback mechanisms that contribute to the complex and potentially oscillatory dynamics of nuclear NFκB. 58, 62 IκBε was shown to provide delayed negative feedback (due to a transcriptional delay) that may partially compensate for the loss of IκBα, 63 and was suggested to dampen IκBα-mediated oscillations by forming a dual, antiphase negative feedback system. 62 There is also evidence that IκBα and ε preferentially inhibit distinct NFκB family members. 64 In B cells, IκBε has been shown to play a key role in regulating cRel containing NFκB dimers, with loss of IκBε resulting in increased B-cell survival and proliferation. 21 Within the TNF pathway, both negative and positive feedback has been reported. Expression of the de-ubiquitinase A20 is strongly NFκB inducible. However, owing to a long protein half-life and enzymatic effector function, its negative feedback effects do not shape NFκB dynamics acutely, but rather integrate the history of prior exposure to render the NFκB pathway less sensitive to subsequent stimuli. 42 TNF itself is NFκB inducible, but for full activation, additional signaling mechanisms controlling splicing, mRNA half-life, pro-TNF processing, and secretion must be activated. 65, 66 Hence, TNF functions more like a feed-forward loop in response to PAMPs rather than a positive feedback loop per se.
NONCANONICAL NFκB SIGNALING
Signaling via NIK and IKKα
Noncanonical signals are NFκB activating signals that are transduced in a NEMO-independent, but NIK and IKKα-dependent manner. Noncanonical pathways activating signals are primarily developmental signals that activate TNF receptors (BAFFR, CD40, LTβR, RANK, TNFR2, Fn14, etc.), some of which also activate the canonical NFκB pathway. [67] [68] [69] [70] [71] [72] [73] [74] Noncanonical NFκB signaling is known to control a wide variety of developmental phenotypes including B-cell survival and maturation, dendritic cell activation, and bone metabolism. 75 Several chemokines that regulate lymphoid organogenesis are induced specifically by noncanonical NFκB activation. 69 Base pair differences in κB sites may contribute to noncanonical pathway-specific gene expression. 76, 77 While canonical signals transduced by NEMO require phosphorylation-dependent activation of the IKK kinase complex, noncanonical signals transduced by NIK require stabilization and accumulation of the kinase, which, in the absence of signal, is rapidly degraded by a TRAF-cIAP complex. 78 This ubiquitination-dependent degradation ensures very low basal NIK levels. 79 Noncanonical stimuli trigger TRAF2-dependent cIAP1-cIAP2 activation, which in turn leads to the proteasomal degradation of TRAF3; this disrupts the cIAP-TRAF complex reducing NIK degradation and leads to accumulation of NIK. [79] [80] [81] NIK activity is dependent on IKK1, but independent of IKK2. Once activated, the NFκB-inducing-kinase (NIK) complex has dual roles within the noncanonical pathway (Figure 2(a) ). Originally identified as a MAP kinase kinase kinase (encoded by Map3k14), NIK activates IKKα by phosphorylation of Ser and Thr residues within an activation loop between subdomains VII and VIII of the kinase domain. 84, 85 Although NIK overexpression results in canonical NFκB activation, 85, 86 NIK knockouts are not defective in the canonical activation of IKK and NFκB in response to inflammatory cytokines. 82 
IκBδ Degradation to Release Preformed Dimers
NIK's first role is in targeting the oligomeric IκB complex, causing IκBδ degradation and release of preexisting NFκB dimers for nuclear localization. 26 This initial response relies on phosphorylation events and occurs quickly, as IκBδ bound to preexisting dimers can release NFκB to localize to the nucleus as soon as it is modified by NIK (Figure 2(b) ). While NIK is primarily considered the transducer of noncanonical NFκB signaling and IκBδ differs from other IκBs in its ability to inhibit RelB-containing dimers and respond to noncanonical stimuli, IκBδ also inhibits RelA-containing dimers. Therefore, NIK-induced IκBδ degradation may induce an inflammatory and/or developmental response depending on the existing NFκB dimer repertoire poised within the cell prior to stimulation. Both RelB and RelA induction in response to LTβR (noncanonical only) are abrogated in NIK knockout.
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P100 Processing to p52 to Generate New RelB:p52
The second role of NIK is in initiating the proteasome-mediated processing of p100 into p52. Phosphorylation of C-terminal serine residues leads to p100 being recognized by SCF/βTRCP ubiquitin ligase and subsequent partial degradation of the ARD by the 26S proteasome. 82, 83 This processing produces a mature p52 monomer that is then able to dimerize to form transcriptionally active RelB:p52 and other NFκB dimers. 87 It appears that only newly translated p100 is able to be processed into p52, 88 probably because p100 oliomerizies into a complex that renders it unavailable for processing. 26 The multidomain interactions between RelB and p52 (and also p100) co-stabilize both proteins, as RelB protein 91 Processing is tightly controlled by a processing-suppressive region in the C-terminal portion of the p100 protein and disruption of this domain leads to constitutive p100 processing. 82, 92 p100 that does not form p52 is free to form highermolecular-weight inhibitors of NFκB (IκBδ), and therefore tight regulation is important to ensure production of IκBδ in the absence of noncanonical stimuli to regulate late-phase NFκB activity. NIKinduced p100 processing, and subsequent dimerization with RelB, is a relatively slow process compared to the release of preexisting NFκB dimer from inhibitor, and therefore this results in a late-phase and sustained gene-expression response.
During B-cell maturation, BAFF activates noncanonical NFκB signaling and the consequence of this is dependent on the state of p100 synthesis within the NFκB network: at moderate p100 synthesis rates BAFF-induced p52 production fully depletes p100 and prevents the formation of IκBδ, whereas in the context of high p100 synthesis and resultant IκBδ formation BAFF causes IκBδ degradation altering cRel activity and affecting B-cell expansion. 61 Constitutive P100 degradation also contributes to p100 homeostasis and hence is important for a variety of cellular functions.
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ALTERNATIVE NFκB ACTIVATION MECHANISMS
Ribotoxic Stress
Ribotoxic stress, as induced by ultraviolet light (UV) exposure or by unfolded protein response (UPR) inducers, has been found to activate NFκB by inhibiting translation of IκBα. 94, 95 Thus, these stimuli engage in crosstalk with inflammatory signaling and amplify NFκB activity (Figure 3(a) ). Indeed, UVinduced activation of NFκB was shown to occur in enucleated cells, eliminating UV-induced DNA damage as the primary transducer of this pathway. Instead, in response to UV, eukaryotic initiation factor 2 α (eIF2α) is phosphorylated through stress response kinases GCN2/PERK. Phosphorylation of eIF2α broadly inhibits transcription initiation, resulting in reduced synthesis of IκBα. 94 As free IκBα is constantly degraded and synthesized, the UV-induced reduction in synthesis results in decreased IκBα and amplified NFκB responses (Figure 3(b) ). Interestingly, in response to chronic reactive oxygen species exposure, NFκB may repress prosurvival genes and induce prodeath genes.
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FIGURE 2 | The noncanonical nuclear factor κ B (NFκB) activation pathway. (a) Schematic depiction of the noncanonical NFκB signaling pathway. Developmental signals activate the NIK/IKK1 complex that phosphorylates p100. Most p100 is found in a higher-molecularweight inhibitory complex (IκBδ). Upon phosphorylation, p100 is processed into p52 and is then available to bind RelB, creating a dimer that localizes to the nucleus and binds DNA to activate transcription. 82, 83 Active NIK/IKK1 complex also phosphorylates the p100 within IκBδ, resulting in its partial degradation and releasing bound NFκB dimers for nuclear localization and gene activation.
Genotoxic Stress
Genotoxic stress also activates NFκB, although through distinct mechanisms. 96 In this context, the initiation signal for NFκB responses originates from within the nucleus and is propagated to the cytosol via mechanisms that involve the nuclear export of upstream signaling molecules. In response to DNA damage NEMO is localized to the nucleus as a result of SUMO-1 attachment. 98 DNA damage-activated ATM (ataxia telangiectasia mutated) then phosphorylates NEMO in the nucleus and triggers monoubiquitination of NEMO. ATM then binds to this modified NEMO, which is exported to the cytoplasm and activates IKK to result in degradation of IκBs. NFκB activation upon genotoxic stress is markedly slower and lower in amplitude than that observed for immune receptor signaling, and its physiological role remains unclear. Ribotoxic stress inducers lead to the phosphorylation of initiation factor eIF2α through the action of kinases GCN2 and PERK. Once active, eIF2α inhibits translation initiation, thereby reducing synthesis of IκBs. 94 The reduction in IκB leads to more free NFκB that localizes to the nucleus and binds DNA to promote target gene expression. Genotoxic stress inducers lead to the phosphorylation of ATM and induce complex formation with NEMO in the nucleus. 96 NEMO is phosphorylated and exported into the cytoplasm where it associates with ELKS and stimulates IKK2-containing complexes. Activation of NEMO/IKK2 complexes results in increased IκB degradation and localization of NFκB to the nucleus. (b) Diagram of the regulatory logic of alternative methods of NFκB activation. UV stress response through GCN2/PERK upregulates eIF2α which in turn suppresses IκBs. The reduced IκB synthesis reduces the inhibition of NFκB and increases nuclear NFκB and target gene expression. In response to DNA damage, ATM is upregulated and activates NEMO through a complex with ELKS. Increased NEMO/IKK2 activation results in suppression of IκBs.
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Shear Stress
Mechanical forces exerted on cells can also activate NFκB. Shear stress (mechanotransduction) activates NFκB in osteoblasts through phospholipase pathways that release intracellular Ca
2+
. Activated NFκB in response to shear stress upregulates COX-2, which plays an important role in the response of bone to mechanical loading. 99 Hemodynamic forces also exert shear stresses on vascular cells during development of atherosclerosis that result in activation of NFκB through a mechanism independent from canonical IκBα degradation.
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NFκB GENERATION MECHANISMS
NFκB dimeric transcription factors are formed by five monomers (Figure 4) . Of the 15 possible dimers, 12 are thought to bind the DNA κB element, and 3 (RelB:RelB, RelB:RelA, and RelB:cRel) form low-affinity intertwined dimers that are unable to bind DNA. 101 Of the 12 DNA-binding dimers, 9 contain at least one of the activator proteins, RelA, cRel, or RelB (RelA being the most potent and RelB the least), and generally function as transcriptional activators. The remaining three (the abundant p50:p50 homodimer, and the lesser p52:p52 and p50:p52 homodimers and heterodimers, respectively) may function as activators in conjunction with co-activators, including Bcl3 and IκBζ.
The mechanisms underlying NFκB dimer generation ( Figure 4 ) have only recently received attention, but are critical to understanding how different cell types produce different NFκB dimer repertoires during cell differentiation and development. In some cases, a shift in the dimer repertoire has been documented: for example, B cells shift from a RelA:p50 predominant state at the pre-B stage to a cRel:p50 dominant state in mature B-lymphoid cells and then show strong upregulation of RelB and p52 in terminally differentiated B cells. 102 Also, while most monocyte lineages rely on RelA:p50, GM-CSF-derived inflammatory dendritic cells show high levels of the unusual RelB:p50 dimer, whose generation was shown to be dependent on high constitutive RelB expression and NIK activity. 35 These examples show that the NFκB dimer repertoire is responsive to stimuli, albeit at longer timescales (>8 h) than the activation of NFκB from the latent dimer repertoire.
NFκB family members are obligate dimers; as monomers they are unstable and are thought to be quickly degraded. Thus, the NFκB dimer generation system is highly dynamic and homeostatic. Below, we summarize the key regulatory mechanisms that FIGURE 4 | Mechanisms regulating nuclear factor κ B (NFκB) dimer generation. (a) Diagram of NFκB monomer synthesis and processing. 10, 20 All NFκB monomers and precursors are NFκB target genes and induced, to varying extents, by NFκB. RelA/RelB/cRel polypeptides are synthesized in a complete form, ready to dimerize into functional NFκB dimers. 61, 104 p105 is a precursor to p50 that must be cleaved in a process thought to be dependent on IKK2. 2 p100 must be processed via a NIK/IKK1-dependent pathway into mature p52 before it can dimerize into NFκB. 82 contribute to the NFκB dimer repertoire. How these function together to determine the specific NFκB signaling system of specific cell types ought to be a focus of future increasingly quantitative studies.
Dimerization Affinities
Key determinants of the NFκB dimer repertoire are the interaction rate constants between the five monomers. Indirect evidence suggests that the 15 NFκB dimers have dramatically different dimerization affinities, yet remarkably little quantitative information has been published. Recently, analytical ultracentrifugation determined the affinities of the RelA:p50, p50:p50, and RelA:RelA dimers to be in the range of 1-5 nM, 20-50 nM, and 0.8-1.5 μM, respectively. 103 It is not unreasonable to speculate that other dimers fall into these orders of magnitude, with large dimers (RelA:cRel, cRel:cRel and the DNA-binding incompetent dimers RelB:RelA, RelB; RelB, and RelB:cRel) having low affinities close to the μM range, small dimers (p50:p52, p52:p52) in the high nM range, and dimers composed of one large and one small subunit (RelA:p52, RelB:p50, RelB:p52, cRel:p50, and cRel:p52) having the tightest affinities. However, even if these broad rules prove correct, differences between them are likely to be important in determining the dimer repertoire. Further, it is likely that association and dissociation rate constants, rather than steady-state affinities derived from ratios of these rates, may also be important, as a slow k on rates will lead to a kinetic disadvantage within this potentially competitive dynamical system. If experimental pipelines are established, we expect that posttranslational modifications will likely be found that modulate these important parameters.
Expression of NFκB Monomer Genes
In order to produce NFκB dimers, a monomer must be expressed, yet given the interdependence of combinatorial dimerization, expression of all monomers must be considered in order to predict the abundance of a single dimer. NFκB monomer genes are known to be expressed differentially. RelA is thought to be ubiquitously expressed at high levels, whereas cRel is largely restricted to lymphoid lineages (as well as inflammatory dendritic cells), and RelB is also known to be expressed at high levels in specific cell types. All NFκB genes are to some degree NFκB inducible, with cRel, RelB, Nfkb1, and Nfkb2 being long-recognized targets of RelA, 61, 104 and RelA recently reported to be a RelA target as well. 105 However, it is unlikely that autoregulation alone accounts for the cell-type-specific expression patterns and little information is available about other transcription factors that control the expression of NFκB genes.
Processing of NFκB Monomer Precursors
Expression of Nfkb1 and Nfkb2 leads to the precursor proteins p105 and p100 that must be processed before the p50 and p52 dimerization partners are available. p105 is endoproteolytically cleaved into a mature protein, p50, that is able to dimerize with other NFκB proteins (predominantly RelA).
2 p105 processing is generally a constitutive process that occurs in unstimulated cells. 106 It is unclear whether IKK2 may process p105 in a signal-responsive manner.
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Nfkb2/p100 must be processed into p52 before it can dimerize, predominantly with RelB, to form an NFκB dimer. In response to developmental signals p52 processing is increased as NIK is activated. 82 p100 to p52 processing is not only significant as it generates p52 but also as it depletes p100 which would otherwise complex into the inhibitory complex IκBδ. Competition for binding to RelA and RelB between p50 and p52 also contributes to p100 processing rate as RelB inhibits p100 to p52 processing. 90 The level of precursor protein controls the maximal signal-responsive induction of protein processing that can be achieved. When elevated, p100 processing depletes the cellular pool of p100 and noncanonical signaling is unable to strongly induce further p52 production or RelB:p52 formation. Similarly, when all RelB is able to bind to p50 (for example, in nfkb2 −/− where no p52 is produced), the pool of precursor p105 is depleted. 90 
Monomer Competition During Dimerization
The combinatorial nature of NFκB dimerization implies the potential for competition between monomers for the generation of specific dimers. This competition was first reported with regard to the formation of RelA:p50 versus RelB:p52, where a slightly higher affinity of p105/p50 for RelA reduces the opportunity for p100/p52 from complexing with RelA. 108 Conversely, a slightly higher affinity of p100/p52 for RelB diminishes the potential formation of RelA:p52 dimers. This model explains the appearance of such dimers in the respective knockouts. 90 More recently, a quantitative analysis of RelA homodimerization and heterodimerization (with p50) revealed the degree to which monomer competition Advanced Review wires.wiley.com/sysbio reduces the abundance of low-affinity dimers 103 : the high-affinity RelA:p50 dimer dramatically reduces the abundance of the low-affinity RelA homodimer, whose formation hence becomes entirely dependent on a chaperone. Only when p50 is genetically diminished does RelA homodimer formation become chaperone independent.
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Dimer Stabilization and Chaperones
In addition to the combinatorial dimerization affinities and physiochemical properties of the monomers, dimer abundances may be enhanced by 'thirdparty' stabilizers, and dimer generation may be enhanced by dimerization chaperones. To date, one such example has been reported 103, 109 : IκBβ was identified as increasing the effective binding affinity of RelA homodimer. 103 As mentioned, RelA homodimer levels suffer not only from a poor affinity but also from competition from RelA:p50 dimerization. This effect is counteracted by IκBβ, which is able to increase the binding of the low-affinity RelA homodimer. A quantitative analysis arrives at such a high effective affinity that a two-step model for IκBβ function is plausible, i.e. that IκBβ binds one monomer first and then a second, enhancing the effective association rate constant and rendering it a bona fide 'chaperone.' However, direct evidence is currently outstanding.
But regardless of whether IκBs function as chaperones or merely stabilizers of specific dimers, their potential role adds a more dynamic and complex component to the control of the cell-type-specific NFκB dimer repertoire, as well as a redefinition of IκBs from being merely inhibitors to also being 'licensing factors' of NFκB activity.
Dimer Degradation
NFκB dimers are thought to be stable when associated with IκBs. They neither come apart nor are they degraded. However, while DNA interactions may also stabilize dimerizing interactions, NFκB dimers bound to DNA are thought to be subject to regulated degradation. Though an attractive hypothesis, the mechanisms remain less than clear. RelA was shown to be removed from specific chromatin sites even in the absence of new IκBα feedback synthesis 110 ; RelA removal from chromatin was impaired in IKKα-deficient macrophages 111 ; and the peptidyl-prolyl isomerase Pin1 and the E3 ligases SOCS1 112 and COMMD1/Cul2 113 have been implicated in RelA degradation.
SIGNALING CROSSTALK MECHANISMS
While the canonical and noncanonical pathways are mediated by distinct kinases and immediate substrates, given the large number of shared components within the NFκB system, there is a great potential for crosstalk between the two pathways.
Noncanonical Control of Canonical Signaling
Nfkb2/p100 is the primary signaling node at which canonical and noncanonical signals interact ( Figure 5  (a) ). That is because (1) Nfkb2 expression is inducible by RelA, (2) any p100 that is not processed into p52 forms a higher-molecular-weight inhibitor of NFκB, the IκBδ-containing IκBsome, that may trap NFκB dimers and thus diminish their association with canonical IκBs, 26, 114 and (3) p100 processing to p52 and IκBδ degradation is triggered by noncanonical NIK activity. As a result, noncanonical signaling may extend the duration of canonical NFκB activation, 61 or in its absence may diminish canonical NFκB activation. 58 Thus, noncanonical pathway activity tunes the potency of the canonical pathway in activating NFκB ( Figure 5(b) ). Interestingly, in conditions with chronically elevated noncanonical activity, as in inflammatory dendritic cells, canonical pathway signaling is not only altered quantitatively but also qualitatively: in GM-CSF-derived dendritic cells, high noncanonical pathway activity diminishes p100 to such a degree that the RelB:p50 dimer forms, which then associates with IκBα (and to some degree IκBε), rendering it responsive to noncanonical signals. 35 Hence, TLR-triggered maturation of these dendritic cells involves activation of RelB:p50, in addition to the expected RelA:p50 and cRel:p50 dimers.
Canonical Control of Noncanonical Signaling
In addition to Nfkb2, the Relb gene is also induced by NFκB dimers in response to canonical pathway activity. 104, 115 Therefore, canonical pathway activity is essential for noncanonical activation of the RelB: p52 dimer. 90 The dependency of noncanonical signaling on canonical activity impacts lymph node development in RelA-deficient mice. 87 This potential for crosstalk may in principle also allow elevated canonical pathway activity to amplify noncanonical activation of RelB:p52 ( Figure  5 (b)), with potentially pathologic consequences. 108 However, this does not appear to be the case-yet the mechanism that insulates canonical signaling from high canonical activity remains to be elucidated.
Posttranslational Modifications
Several posttranslational modifications of RelA have been identified, including phosphorylation of serines and threonines in the DNA binding and activation domains, methylation, acetylation, and glycosylation. 116, 117 Mutational analysis of the modification acceptor residues has in many cases been shown to have detrimental effects on proper NFκB control and target gene expression, and it appears that a variety of regulatory steps (e.g., nuclear localization, DNA binding, and co-activator recruitment) may be affected. However, in many cases, it remains unclear whether the posttranslational modification occurs constitutively, is induced by the same stimulus as IκB degradation, or may in fact be induced by a different stimulus or cell-type specifically. Evidence for the latter scenario would support the attractive hypothesis that NFκB proteins function as integrators of distinct signals (to control nuclear localization and posttranslational modifications) to fine-tune NFκB-responsive transcriptional programs. Such a scenario would suggest a signaling crosstalk that ought to be examined with a range of biochemical, cell biological, and computational research tools.
SUMMARY
NFκB has been a key nexus of scientific interest over the past several decades. The breadth and depth of investigation, and the compiled knowledge of this key family of transcription factors are unparalleled. From early insights into its function as a transcription factor and immune response regulator to later studies on cellular signaling, dynamical responses, gene regulatory networks, and feedback mechanisms, it is clear that NFκB has become a standard bearer for research into the inner workings of cellular communication and signal response paradigms. New work on signaling crosstalk and remaining questions and challenges in the field, an amenability to signaling and information transmission studies informed by computational modeling, as well as NFκB's continued interest as a therapeutic target ensure a future of extensive interest and publication on the subject. Ongoing work to expand the scope of computational models and extend their applicability from the cellular scale to the tissue scale will require agent-based 
